טוען...
Incidence of Pneumocystis jirovecii pneumonia after temozolomide for CNS malignancies without prophylaxis
AIMS: Prophylaxis against Pneumocystis jiroveci pneumonia (PJP) is currently recommended for patients receiving chemoradiation with temozolomide for newly diagnosed glioblastoma multiforme. At our institution, PJP prophylaxis during temozolomide treatment has not been routinely given because of the...
שמור ב:
| הוצא לאור ב: | CNS Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Future Medicine Ltd
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6124367/ https://ncbi.nlm.nih.gov/pubmed/25286038 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns.14.24 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|